Canterbury DHB



The WHO Classification appeared in a 4th edition in 2008 and underwent a significant revision in 2016. For a review of the 2016 revision, see Swerdlow, S.H., Campo, E. (2016). "The 2016 revision of the World Health Organization classification of lymphoid neoplasms." Blood 127: 2375-90.

B-cell lymphomas – 80%

T-cell lymphomas – 20%


  • CLL/small lymphocytic lymphoma
  • Lymphoplasmacytic lymphoma
  • Waldenstrom’s macroglobulinemia
  • Splenic B-cell marginal zone lymphoma
  • Extra-nodal marginal zone B-cell lymphoma of MALT
  • Nodal marginal zone lymphoma
  • Follicular lymphoma
  • Extranodal follicular lymphoma
  • Primary intestinal follicular lymphoma
  • Mycosis Fungoides / Sezary syndrome
  • Primary cutaneous anaplastic large cell
  • Subcutaneous panniculitis-like T-cell lymphoma


  • Diffuse large B-cell:
    • Germinal Centre Cell origin
    • Activated B cell origin
  • DLBCL, subtypes T-cell/histiocyte rich large B-cell lymphoma (primary DLBCL of CNS and primary cutaneous DLBCL)
  • Primary mediastinal (thymic) large B-cell lymphoma
  • Intravascular DLBCL
  • Lymphomatoid granulomatosis
  • ALK-positive DLBCL
  • Primary effusion lymphoma
  • DLBCL associated with inflammation
  • Plasmablastic lymphoma
  • Burkitt’s lymphoma
  • Large B-cell lymphoma arising in HHV8 associated with Castleman’s disease
  • Precursor B lymphoblastic
  • Anaplastic large cell lymphoma, ALK-positive (ALCL, ALK+)
  • Anaplastic large cell lymphoma, ALK-negative (ALCL, ALK-)
  • Peripheral T-cell lymphoma, NOS
  • Adult T-cell leukaemia / lymphoma
  • Extra-nodal NK/T-cell lymphoma, nasal type
  • Hepatosplenic T cell lymphoma
  • Enteropathy associated T-cell lymphoma
  • Angio-immunoblastic T-cell lymphoma
  • Precursor T-lymphoblastic

About this Canterbury DHB document (6406):

Document Owner:

Peter Ganly (see Who's Who)

Last Reviewed:

December 2021

Next Review:

December 2024


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 6406